
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
Lena Peter, Désirée J. Wendering, Stephan Schlickeiser, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 25, pp. 52-73
Open Access | Times Cited: 13
Lena Peter, Désirée J. Wendering, Stephan Schlickeiser, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 25, pp. 52-73
Open Access | Times Cited: 13
Showing 13 citing articles:
TGFβ links EBV to multisystem inflammatory syndrome in children
Carl Christoph Goetzke, Mona Massoud, Stefan Frischbutter, et al.
Nature (2025)
Open Access | Times Cited: 1
Carl Christoph Goetzke, Mona Massoud, Stefan Frischbutter, et al.
Nature (2025)
Open Access | Times Cited: 1
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective
Leila Amini, Jaspal Kaeda, Enrico Fritsche, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 19
Leila Amini, Jaspal Kaeda, Enrico Fritsche, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 19
Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond
Αναστασία Παπαδοπούλου, Maria V. Alvanou, George Karavalakis, et al.
HemaSphere (2023) Vol. 7, Iss. 1, pp. e809-e809
Open Access | Times Cited: 11
Αναστασία Παπαδοπούλου, Maria V. Alvanou, George Karavalakis, et al.
HemaSphere (2023) Vol. 7, Iss. 1, pp. e809-e809
Open Access | Times Cited: 11
Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular Therapies
Holly Wobma, Francesca Alvarez Calderon, Jiayi Dong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Holly Wobma, Francesca Alvarez Calderon, Jiayi Dong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review
László Gopcsa, Marienn Réti, Hajnalka Andrikovics, et al.
GeroScience (2023) Vol. 46, Iss. 1, pp. 1083-1106
Open Access | Times Cited: 4
László Gopcsa, Marienn Réti, Hajnalka Andrikovics, et al.
GeroScience (2023) Vol. 46, Iss. 1, pp. 1083-1106
Open Access | Times Cited: 4
The Natural History of SARS-CoV-2-Incurred Disease: From Infection to Long COVID
Kung–Hao Liang, Yuan‐Chi Teng, Yiting Liao, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 1, pp. 72-86
Open Access | Times Cited: 1
Kung–Hao Liang, Yuan‐Chi Teng, Yiting Liao, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 1, pp. 72-86
Open Access | Times Cited: 1
SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?
José Luís Piñana, Manuel Guerreiro, Carlos Solano
Hemato (2023) Vol. 4, Iss. 2, pp. 170-183
Open Access | Times Cited: 3
José Luís Piñana, Manuel Guerreiro, Carlos Solano
Hemato (2023) Vol. 4, Iss. 2, pp. 170-183
Open Access | Times Cited: 3
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy
Qi Chen, Adeline Chia, Shou Kit Hang, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 11, pp. 1300-1312
Open Access | Times Cited: 2
Qi Chen, Adeline Chia, Shou Kit Hang, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 11, pp. 1300-1312
Open Access | Times Cited: 2
Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination
Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, et al.
Haematologica (2022) Vol. 108, Iss. 7, pp. 1934-1939
Open Access | Times Cited: 3
Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, et al.
Haematologica (2022) Vol. 108, Iss. 7, pp. 1934-1939
Open Access | Times Cited: 3
Virus-Specific T Cells From Cryopreserved Blood During an Emergent Virus Outbreak for a Potential Off-the-Shelf Therapy
Rut Mora‐Buch, Maria Tomás‐Marín, Emma Enrich, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 9, pp. 572.e1-572.e13
Open Access | Times Cited: 1
Rut Mora‐Buch, Maria Tomás‐Marín, Emma Enrich, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 9, pp. 572.e1-572.e13
Open Access | Times Cited: 1
Immunologic response and seroconversion following third-dose COVID-19 vaccination in solid organ transplant recipients: A meta-analysis
Richard Christian Suteja, Albert Salim, I Putu Divanaya Suryanov, et al.
Transplant Immunology (2023) Vol. 80, pp. 101902-101902
Closed Access | Times Cited: 1
Richard Christian Suteja, Albert Salim, I Putu Divanaya Suryanov, et al.
Transplant Immunology (2023) Vol. 80, pp. 101902-101902
Closed Access | Times Cited: 1
A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection
Michaela Su-Fern Seng, King Pan Ng, Teck Guan Soh, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1170-1178
Open Access
Michaela Su-Fern Seng, King Pan Ng, Teck Guan Soh, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1170-1178
Open Access
Experience in manufacturing a haploidentical biomedical cell product enriched with regulatory T-lymphocytes
Viktoria Vedmedskaia, Dmitry Pershin, Maria Fadeeva, et al.
Pediatric Hematology/Oncology and Immunopathology (2024) Vol. 23, Iss. 2, pp. 48-59
Closed Access
Viktoria Vedmedskaia, Dmitry Pershin, Maria Fadeeva, et al.
Pediatric Hematology/Oncology and Immunopathology (2024) Vol. 23, Iss. 2, pp. 48-59
Closed Access
Terrific cells for SARS-CoV-2
Stephen Gottschalk
Haematologica (2022) Vol. 108, Iss. 7, pp. 1724-1725
Open Access
Stephen Gottschalk
Haematologica (2022) Vol. 108, Iss. 7, pp. 1724-1725
Open Access